Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc.

Overview
Date Founded

1997

Headquarters

11500 South Eastern Avenue, Suite 240, Henderson, NV, 89052, USA

Type of Company

Public

Employees (Worldwide)

235

Industries

Pharmaceuticals
Hospitals & Patient Services
Biotechnology

Company Description

Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development, and commercialization of pipeline of late-stage clinical and commercial products. It operates through the following brands: FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ, and EVOMELA. The company was founded in December 1987 and is headquartered in Henderson, NV.

Contact Data
Trying to get in touch with decision makers at Spectrum Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Executive Vice President, Chief Financial Officer & Chief Accounting Officer

Chief Operating Officer & Chief Commercial Officer

Senior Vice President, Chief Scientific Officer & Head of Research & Development Operations

Chief Legal Officer

Chief Medical Officer

Senior Vice President, Pharmaceutical Operations

Senior Vice President, Corporate Strategy & Operations

Vice President, Pharmaceuticals Operations

Vice President, Sales

Board of Directors

Principal at Harrison Consulting Group, Inc.

Chief Executive Officer at Spectrum Pharmaceuticals, Inc.

Medical Director-Integrated Oncology Network at AmerisourceBergen Corporation

Former Chief Executive Officer, Founder at Axonics Modulation Technologies, Inc.

Managing Partner at Bear Stearns Health Innoventures LP

Assistant Professor, Department of Medicine at UCSF School of Medicine

Former Executive Vice President & Chief Scientific Officer at Astex Pharmaceuticals, Inc.

Executive Chairman at JenaValve Technology, Inc.

Paths to Spectrum Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Spectrum Pharmaceuticals, Inc.
Owners & Shareholders
Details Hidden

Selectra Management Co. SA is a Luxembourgish private company located in Luxembourg with a presence in LU that provides investment advice. It was founded in 2013 by Marco Caldana. Marco Cipolla is currently the CEO of the firm.

Details Hidden

Selectra Management Co. SA is a Luxembourgish private company located in Luxembourg with a presence in LU that provides investment advice. It was founded in 2013 by Marco Caldana. Marco Cipolla is currently the CEO of the firm.

Recent Transactions
Details Hidden

Spectrum Pharmaceuticals, Inc. purchases Talon Therapeutics, Inc. from Warburg Pincus LLC

Details Hidden

Spectrum Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Spectrum Pharmaceuticals, Inc. purchases Allos Therapeutics, Inc.

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Legal Advisor

Advised onSpectrum Pharmaceuticals, Inc. purchases Talon Therapeutics, Inc. from Warburg Pincus LLC

Investment Advisor

Advised onSpectrum Pharmaceuticals, Inc. purchases Talon Therapeutics, Inc. from Warburg Pincus LLC

Legal Advisor

Advised onSpectrum Pharmaceuticals, Inc. purchases Allos Therapeutics, Inc.

Corporate Officer

Advised onSpectrum Pharmaceuticals, Inc. purchases Talon Therapeutics, Inc. from Warburg Pincus LLC

Legal Advisor

Advised onSpectrum Pharmaceuticals, Inc. purchases Talon Therapeutics, Inc. from Warburg Pincus LLC

Associate

Advised onSpectrum Pharmaceuticals, Inc. purchases Allos Therapeutics, Inc.

Advisors & Consultants
Legal Advisor

Partner at Latham & Watkins LLP

Legal Advisor

Shareholder at Stradling, Yocca Carlson & Rauth PC

Advisor

President & Chief Executive Officer at Daiichi Sankyo, Inc.

Clients

Nippon Kayaku Co., Ltd. engages in the manufacture and sale of chemicals. It operates through the following segments: Functional Chemicals, Pharmaceuticals, Safety Systems, and Other. The Functional Chemicals segment provides products in the environment and energy conservation fields based on dye and resin technology. The Pharmaceuticals segment centers on anti-cancer drugs and cancer related fields. The Safety Systems segment handles the improvement of automobile safety through applied explosive technologies that includes airbag inflators and gas generators. The Other segment deals with agrochemicals and real estate leasing. The company was founded by Jotaro Yamamoto, Naokichi Kaneko, and Soubei Mogi on June 5, 1916 and is headquartered in Tokyo, Japan.

Key Stats and Financials As of 2018
Market Capitalization
$272M
Total Enterprise Value
$700M
Earnings Per Share
$-1.16
Revenue
$109M
Net Profit
$-120M
EBITDA
$-103M
EBITDAMargin
-94%
Total Debt
$0
Total Equity
$283M
Enterprise Value Sales
6.4x
TEVNet Income
-5.83x
Debt TEV
0x
Non-Profit Donations & Grants
$25K - $50K
2018
$50K - $100K
2017
$5,000 - $10K
2017
Suppliers
Arbutus Biopharma Corp. Medical Support Services | Burnaby, Canada

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.

Hanmi Pharmaceutical Co., Ltd. Pharmaceuticals | Hwaseong, South Korea

Hanmi Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for high blood pressure, hyperlipidemia, reflux esophagitis, and cerebrovascular disease. The company was founded by Lim Sung-Gi on June 15, 1973 and is headquartered in Hwaseong, South Korea.

Onxeo SA Biotechnology | Paris, France

Onxeo SA is a biotechnology company, which engages in the development of drugs for the treatment of orphan diseases. It produces and develops ophan oncology products under the brand names Livatag, Validive, Beleodaq and AsiDNA. The company was founded by Gilles Avenard and Dominique Costantini on March 5, 1997 and is headquartered in Paris, France.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Mylan NV Pharmaceuticals - Hatfield, United Kingdom

Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.

Amgen, Inc. Biotechnology - Thousand Oaks, CA

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Spectrum Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Spectrum Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Spectrum Pharmaceuticals, Inc..